|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||2.03|
|PE ratio (TTM)||N/A|
|Earnings date||28 Sept 2023 - 02 Oct 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
In a striking contrast of fortunes in the Exchange-Traded Fund (ETF) market on Friday, the Uranium ETF outperformed its peers, while the ARK Genomic Revolution ETF struggled.
It's been a bumper week for uranium stocks, with shares of Uranium Energy (NYSEMKT: UEC) and NexGen Energy (NYSE: NXE) clocking some of the biggest gains in the industry. While Uranium Energy stock surged 19.1% at its highest point in trading during the week through noon Friday, shares of NexGen Energy jumped 16.3% at its highest, according to data provided by S&P Global Market Intelligence. Uranium prices just hit levels not seen in 12 years, and investors don't want to miss the boom.
Uranium Energy Corp (NYSE American: UEC), the "Company" or "UEC") is pleased to announce that the Company has closed a purchase agreement with Rio Tinto Exploration Canada Inc., a subsidiary of Rio Tinto Inc. ("Rio Tinto"), to acquire a portfolio of exploration-stage projects in the Athabasca Basin, Saskatchewan, Canada for $1,500,000 (CAD) (the "Transaction"). The Company has acquired a 60% equity stake in the Henday Lake joint venture ("Henday"), 100% of the Milliken project ("Milliken"), and